Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Kochanny

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
JAMA Network Open|November 19, 2020
Machine Learning-Guided Adjuvant Treatment of Head and Neck CancerFrederick Matthew Howard, Sara Kochanny, Matthew Koshy, et al.
Cancer Gene Therapy|July 31, 2024
Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximabArun Khattri, Nizamuddin Sheikh, Nikhil Agrawal, et al.
Head & Neck|September 6, 2019
A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancerRyan J Brisson, Sara Kochanny, Saba Arshad, et al.
BMC Bioinformatics|March 28, 2024
Slideflow: deep learning for digital histopathology with real-time whole-slide visualizationJames M Dolezal, Sara Kochanny, Emma Dyer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 10, 2020
Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear featuresJames M Dolezal, Anna Trzcinska, Chih-Yi Liao, et al.
Frontiers in Medicine|March 24, 2023
Data augmentation and multimodal learning for predicting drug response in patient-derived xenografts from gene expressions and histology imagesAlexander Partin, Thomas Brettin, Yitan Zhu, et al.
Ebiomedicine|August 28, 2024
Developing a low-cost, open-source, locally manufactured workstation and computational pipeline for automated histopathology evaluation using deep learningDivya Choudhury, James M Dolezal, Emma Dyer, et al.
Nature Communications|July 21, 2021
The impact of site-specific digital histology signatures on deep learning model accuracy and biasFrederick M Howard, James Dolezal, Sara Kochanny, et al.
NPJ Breast Cancer|April 14, 2023
Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrenceFrederick M Howard, James Dolezal, Sara Kochanny, et al.
Cancer|May 5, 2020
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO studyTanguy Y Seiwert, Sara Kochanny, Kevin Wood, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
JAMA Network Open|November 19, 2020
Machine Learning-Guided Adjuvant Treatment of Head and Neck CancerFrederick Matthew Howard, Sara Kochanny, Matthew Koshy, et al.
Cancer Gene Therapy|July 31, 2024
Switching anti-EGFR antibody re-sensitizes head and neck cancer patient following acquired resistance to cetuximabArun Khattri, Nizamuddin Sheikh, Nikhil Agrawal, et al.
Head & Neck|September 6, 2019
A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancerRyan J Brisson, Sara Kochanny, Saba Arshad, et al.
BMC Bioinformatics|March 28, 2024
Slideflow: deep learning for digital histopathology with real-time whole-slide visualizationJames M Dolezal, Sara Kochanny, Emma Dyer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 10, 2020
Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear featuresJames M Dolezal, Anna Trzcinska, Chih-Yi Liao, et al.
Frontiers in Medicine|March 24, 2023
Data augmentation and multimodal learning for predicting drug response in patient-derived xenografts from gene expressions and histology imagesAlexander Partin, Thomas Brettin, Yitan Zhu, et al.
Ebiomedicine|August 28, 2024
Developing a low-cost, open-source, locally manufactured workstation and computational pipeline for automated histopathology evaluation using deep learningDivya Choudhury, James M Dolezal, Emma Dyer, et al.
Nature Communications|July 21, 2021
The impact of site-specific digital histology signatures on deep learning model accuracy and biasFrederick M Howard, James Dolezal, Sara Kochanny, et al.
NPJ Breast Cancer|April 14, 2023
Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrenceFrederick M Howard, James Dolezal, Sara Kochanny, et al.
Cancer|May 5, 2020
A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO studyTanguy Y Seiwert, Sara Kochanny, Kevin Wood, et al.
Pageof 3